Cargando…

Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster

There are currently two authorized vaccines against herpes zoster (HZ) that have been shown to be safe and effective in its prevention: Zostavax, a zoster vaccine live (ZVL), and Shingrix, a recombinant zoster Vaccine (RZV). Because ophthalmologists work with vision-threatening complications of zost...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Mellado, Alberto, Alcaraz-Clemente, Luis, Rodríguez-Calvo-de-Mora, Marina, Sánchez-González, José-María, Ortiz-Perez, Santiago, Rocha-de-Lossada, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222619/
https://www.ncbi.nlm.nih.gov/pubmed/37243056
http://dx.doi.org/10.3390/vaccines11050952
_version_ 1785049742584053760
author Sánchez-Mellado, Alberto
Alcaraz-Clemente, Luis
Rodríguez-Calvo-de-Mora, Marina
Sánchez-González, José-María
Ortiz-Perez, Santiago
Rocha-de-Lossada, Carlos
author_facet Sánchez-Mellado, Alberto
Alcaraz-Clemente, Luis
Rodríguez-Calvo-de-Mora, Marina
Sánchez-González, José-María
Ortiz-Perez, Santiago
Rocha-de-Lossada, Carlos
author_sort Sánchez-Mellado, Alberto
collection PubMed
description There are currently two authorized vaccines against herpes zoster (HZ) that have been shown to be safe and effective in its prevention: Zostavax, a zoster vaccine live (ZVL), and Shingrix, a recombinant zoster Vaccine (RZV). Because ophthalmologists work with vision-threatening complications of zoster, such as herpes zoster ophthalmicus (HZO), they are in a good position to advocate for vaccination. Our aim was to determine the current knowledge among Spanish ophthalmologists about the effectiveness of the available vaccines against HZ. A Google Forms questionnaire was created and used as the survey platform for this study. It was an anonymous online survey of 16 questions, which was shared among Spanish ophthalmologists in-training and consultants from 27 April 2022 to 25 May 2022. The survey was completed by a total of 206 ophthalmologists of all subspecialties. We obtained responses from 17 of the 19 regions of Spain. Fifty-five percent of the respondents agreed that HZ is a frequent cause of vision loss. However, 27% of the professionals were unaware of the existence of vaccines against HZ and 71% of them did not know in which cases it could be indicated. Only nine ophthalmologists (4%) had ever suggested vaccination against HZ to their patients. Despite this, 93% considered it important to recommend vaccination against HZ if it proved to be safe and effective. Considering the sequelae, complications, and the existence of safe and effective vaccines against HZ, vaccination of the target population could be considered an important public health measure. We are convinced that it is time for ophthalmologists to take an active role in HZO prevention.
format Online
Article
Text
id pubmed-10222619
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102226192023-05-28 Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster Sánchez-Mellado, Alberto Alcaraz-Clemente, Luis Rodríguez-Calvo-de-Mora, Marina Sánchez-González, José-María Ortiz-Perez, Santiago Rocha-de-Lossada, Carlos Vaccines (Basel) Communication There are currently two authorized vaccines against herpes zoster (HZ) that have been shown to be safe and effective in its prevention: Zostavax, a zoster vaccine live (ZVL), and Shingrix, a recombinant zoster Vaccine (RZV). Because ophthalmologists work with vision-threatening complications of zoster, such as herpes zoster ophthalmicus (HZO), they are in a good position to advocate for vaccination. Our aim was to determine the current knowledge among Spanish ophthalmologists about the effectiveness of the available vaccines against HZ. A Google Forms questionnaire was created and used as the survey platform for this study. It was an anonymous online survey of 16 questions, which was shared among Spanish ophthalmologists in-training and consultants from 27 April 2022 to 25 May 2022. The survey was completed by a total of 206 ophthalmologists of all subspecialties. We obtained responses from 17 of the 19 regions of Spain. Fifty-five percent of the respondents agreed that HZ is a frequent cause of vision loss. However, 27% of the professionals were unaware of the existence of vaccines against HZ and 71% of them did not know in which cases it could be indicated. Only nine ophthalmologists (4%) had ever suggested vaccination against HZ to their patients. Despite this, 93% considered it important to recommend vaccination against HZ if it proved to be safe and effective. Considering the sequelae, complications, and the existence of safe and effective vaccines against HZ, vaccination of the target population could be considered an important public health measure. We are convinced that it is time for ophthalmologists to take an active role in HZO prevention. MDPI 2023-05-05 /pmc/articles/PMC10222619/ /pubmed/37243056 http://dx.doi.org/10.3390/vaccines11050952 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Sánchez-Mellado, Alberto
Alcaraz-Clemente, Luis
Rodríguez-Calvo-de-Mora, Marina
Sánchez-González, José-María
Ortiz-Perez, Santiago
Rocha-de-Lossada, Carlos
Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title_full Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title_fullStr Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title_full_unstemmed Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title_short Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster
title_sort surveying a sample of the spanish ophthalmologic community about vaccination against herpes zoster
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222619/
https://www.ncbi.nlm.nih.gov/pubmed/37243056
http://dx.doi.org/10.3390/vaccines11050952
work_keys_str_mv AT sanchezmelladoalberto surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster
AT alcarazclementeluis surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster
AT rodriguezcalvodemoramarina surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster
AT sanchezgonzalezjosemaria surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster
AT ortizperezsantiago surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster
AT rochadelossadacarlos surveyingasampleofthespanishophthalmologiccommunityaboutvaccinationagainstherpeszoster